Systemic C-peptide supplementation ameliorates retinal neurodegeneration by inhibiting VEGF-induced pathological events in diabetes.

RPEP-070802023RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Systemic C-peptide supplementation ameliorates retinal neurodegeneration by inhibiting VEGF-induced pathological events in diabetes.
Published In:
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 37(2), e22763 (2023)
Database ID:
RPEP-07080

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-07080·https://rethinkpeptides.com/research/RPEP-07080

APA

Lee, Ah-Jun; Moon, Chan-Hee; Lee, Yeon-Ju; Jeon, Hye-Yoon; Park, Won Sun; Ha, Kwon-Soo. (2023). Systemic C-peptide supplementation ameliorates retinal neurodegeneration by inhibiting VEGF-induced pathological events in diabetes.. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 37(2), e22763. https://doi.org/10.1096/fj.202201390RR

MLA

Lee, Ah-Jun, et al. "Systemic C-peptide supplementation ameliorates retinal neurodegeneration by inhibiting VEGF-induced pathological events in diabetes.." FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2023. https://doi.org/10.1096/fj.202201390RR

RethinkPeptides

RethinkPeptides Research Database. "Systemic C-peptide supplementation ameliorates retinal neuro..." RPEP-07080. Retrieved from https://rethinkpeptides.com/research/lee-2023-systemic-cpeptide-supplementation-ameliorates

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.